Henry Schein Inc

Financials

İşletme faaliyetlerinden elde edilen nakit 204 M37 M120 M174 M381 M 712 M Yatırım faaliyetlerinden elde edilen nakit -58 M-99 M-98 M-56 M-147 M -400 M Finansman faaliyetlerinden elde edilen nakit -204 M89 M56 M-127 M-206 M -188 M Free cash flow 168 M6 M88 M141 M338 M 573 M

Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world’s largest provider of health care solutions to office-based dental and medical practitioners.

HSIC

Financials

Henry Schein Inc

Haberler

BTIG, Henry Schein hissesi için mütevazı büyüme gerekçesiyle Nötr önerisiyle kapsama başladı

Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term

What to Expect From Henry Schein’s Q1 2026 Earnings Report

Henry Schein yönetim kurulu yıllık toplantı sonrası 10 üyeye inecek

Should You Retain Henry Schein Stock in Your Portfolio for Now?

ISRG's Margins Contract in Q4: Will Tariffs Continue to Hurt in 2026?

Align Technology: Only International Growth Can Save Them Now (Downgrade) (NASDAQ:ALGN)

Piper Sandler’a göre en iyi tıbbi teknoloji hisseleri

Henry Schein Barclays Konferansı: Dijital Genişleme ve Pazar Kazanımları

Henry Schein at Barclays Conference: Digital Expansion and Market Gains

Henry Schein, Inc. (HSIC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Leerink Partners, Henry Schein hissesi için hedef fiyatı 87 dolar olarak korudu